Mario Gabelli Chroma Dex Corp. Transaction History
Gamco Investors, Inc. Et Al
- $9 Billion
- Q3 2024
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 143,150 shares of CDXC stock, worth $976,283. This represents 0.01% of its overall portfolio holdings.
Number of Shares
143,150
Previous 233,150
38.6%
Holding current value
$976,283
Previous $636,000
17.92%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CDXC
# of Institutions
94Shares Held
17.2MCall Options Held
66.7KPut Options Held
8.2K-
Vanguard Group Inc Valley Forge, PA3.43MShares$23.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$21.3 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$20.2 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$8.84 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$7.84 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $466M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...